Why Australia & New Zealand Banking Group's new strategy will deliver for investors

The Australia & New Zealand Banking Group's (ASX:ANZ) new strategy could deliver for shareholders in the years ahead.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australia & New Zealand Banking Group (ASX: ANZ) handed down a half-year statutory profit of $2.9 billion this morning to kick off the bank earnings season in a positive manner for the wider market.

The statutory profit was 6% above the prior corresponding period's, with adjusted pro-forma profit and earnings per share lifting an impressive 13% and 12% respectively over the prior period.

The group attributed the improved performance to a restructure of the business after it moved to divest several of its Asian operations and its local life insurance business over the past year.

The new CEO's flagship strategy to dump asset-heavy insurance operations and retail banking businesses across six Asian countries is motivated by the goal to improve the bank's capital adequacy ratio and return on equity via asset sales, rather than cutting dividends or raising equity.

The results of the strategy shine through in today's result with return on equity up a bumper 2.1% over the prior corresponding half to 11.8% and the bank's capital adequacy ratio lifting above 10% for the first time since 2010.

In effect the group's operations outside the less profitable ANZ regions are being cut back, with over 50% of group capital now allocated to home loan, personal and business lending in ANZ, compared to 44% in the prior corresponding period. The likely side effect of this strategy is lifting the bank's capital adequacy ratio as its loan book into lower risk weighted assets.

Recently regulators have toughened up requirements as to how much capital banks must keep in reserve on their balance sheets as a proportion of their lending books on a risk weighted basis and this is what has dragged down profitability (as lending restrictions are tighter) in exchange for delivering a securer and less leveraged financial system.

Like other banks, ANZ has also benefited from the strength of Australia's residential property market with home lending up 5% and small business lending up 4% over the prior period.

The group's net interest margin (NIM), as a key measure of profitability, contracted 7 basis points to 2%, versus 2.07% over the prior period. Banks generally lend long term and borrow short term, with the difference between what they pay on what they borrow, versus what they make on what they lend known as the NIM.

Outlook

ANZ held its interim dividend steady at 80 cents per share, with the medium-term strategy likely to be returning the payout amount to FY 2015's higher levels on the back of a rising return on equity and elevated capital adequacy.

ANZ looks a decent prospect given the CEO's profit-boosting Asian divestment strategy is not rocket science and it was regularly trumpeted as a key driver of the group's improved performance metrics in today's update. Given the strategy appears to be paying off with plenty of time ahead to deliver dividend-boosting progress, I expect the shares could do well over the next few years.

Later in the week both Westpac Banking Corp (ASX: WBC) and Macquarie Group Ltd (ASX: MQG) will reveal their financial results to the market. In the banking space I would prefer Macquarie as a long-term investment option thanks to its adaptability and flexibility to generate consistent profit growth over the long term.

Motley Fool contributor Tom Richardson owns shares of Macquarie Group Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »